Panbela Therapeutics Analyst Ratings
Panbela Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Panbela Therapeutics (PBLA) rating was a reiterated with a price target of $0.00 to $16.00. The current price Panbela Therapeutics (PBLA) is trading at is $2.38, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/10/2023 | 572.27% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy |
| 06/13/2023 | 572.27% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy |
| 06/02/2023 | 572.27% | HC Wainwright & Co. | $7 → $16 | Reiterates | → Buy |
| 05/05/2023 | 194.12% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 04/26/2023 | 194.12% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 03/20/2023 | -36.97% | Maxim Group | → $1.5 | Upgrades | Hold → Buy |
| 01/31/2023 | 320.17% | Roth Capital | → $10 | Reinstates | → Buy |
| 10/12/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 06/28/2021 | 320.17% | Roth Capital | → $10 | Initiates Coverage On | → Buy |
| 03/10/2021 | 236.13% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 07/10/2023 | 572.27% | HC Wainwright & Co. | → 16 美元 | 重申 | 购买 → 购买 |
| 06/13/2023 | 572.27% | HC Wainwright & Co. | → 16 美元 | 重申 | 购买 → 购买 |
| 06/02/2023 | 572.27% | HC Wainwright & Co. | 7 美元 → 16 美元 | 重申 | → 购买 |
| 05/05/2023 | 194.12% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 2023 年 4 月 26 日 | 194.12% | HC Wainwright & Co. | → 7 美元 | 开启覆盖范围 | → 购买 |
| 03/20/2023 | -36.97% | 马克西姆集团 | → 1.5 美元 | 升级 | 持有 → 买入 |
| 01/31/2023 | 320.17% | 罗斯资本 | → 10 美元 | 恢复 | → 购买 |
| 2022 年 12 月 10 日 | — | 马克西姆集团 | 降级 | 买入 → 持有 | |
| 06/28/2021 | 320.17% | 罗斯资本 | → 10 美元 | 开启覆盖范围 | → 购买 |
| 2021 年 10 月 3 日 | 236.13% | 马克西姆集团 | → 8 美元 | 开启覆盖范围 | → 购买 |
What is the target price for Panbela Therapeutics (PBLA)?
Panbela Therapeutics（PBLA）的目标价格是多少？
The latest price target for Panbela Therapeutics (NASDAQ: PBLA) was reported by HC Wainwright & Co. on July 10, 2023. The analyst firm set a price target for $16.00 expecting PBLA to rise to within 12 months (a possible 572.27% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年7月10日公布了Panbela Therapeutics（纳斯达克股票代码：PBLA）的最新目标股价。这家分析公司将目标股价定为16.00美元，预计PBLA将在12个月内升至12个月内（可能上涨572.27％）。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Panbela Therapeutics (PBLA)?
分析师对Panbela Therapeutics（PBLA）的最新评级是多少？
The latest analyst rating for Panbela Therapeutics (NASDAQ: PBLA) was provided by HC Wainwright & Co., and Panbela Therapeutics reiterated their buy rating.
Panbela Therapeutics（纳斯达克股票代码：PBLA）的最新分析师评级由HC Wainwright & Co. 提供，Panbela Therapeutics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Panbela Therapeutics (PBLA)?
Panbela Therapeutics（PBLA）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Panbela Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Panbela Therapeutics was filed on July 10, 2023 so you should expect the next rating to be made available sometime around July 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Panbela Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Panbela Therapeutics的最后一次评级是在2023年7月10日提交的，因此你应该预计下一个评级将在2024年7月10日左右公布。
Is the Analyst Rating Panbela Therapeutics (PBLA) correct?
分析师对 Panbela Therapeutics (PBLA) 的评级正确吗？
While ratings are subjective and will change, the latest Panbela Therapeutics (PBLA) rating was a reiterated with a price target of $0.00 to $16.00. The current price Panbela Therapeutics (PBLA) is trading at is $2.38, which is within the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Panbela Therapeutics（PBLA）评级得到了重申，目标股价为0.00美元至16.00美元。Panbela Therapeutics（PBLA）目前的交易价格为2.38美元，在分析师的预测区间内。